Compound Report Overview
Compound Name:
AURANOFIN
Compound Identifier:
602331
Mol Structure 2D:
602331
Molecular Weight:
678
Formula:
C20 H34 Au O9 P S
Development Status:
US FDA Approved
SMILES:
CCP(=[Au]SC1OC(COC(=O)C)C(OC(=O)C)C(OC(=O)C)C1OC(=O)C)(CC)CC
Compound Activites
| Compound | Assay | Assay Name | View |
|---|---|---|---|
| AURANOFIN | 84 | Adrenergic alpha2A | View |
| AURANOFIN | 619 | Adenosine A3 | View |
| AURANOFIN | 85 | Adrenergic alpha2B | View |
| AURANOFIN | 639 | Thromboxane Synthetase | View |
| AURANOFIN | 57 | Protein Serine/Threonine Kinase, ERK1 | View |
| AURANOFIN | 644 | CYP450-3A4 Inhibition | View |
| AURANOFIN | 103 | Calcium Channel Type L, Phenylalkylamine | View |
| AURANOFIN | 621 | Chemokine CCR2B | View |
| AURANOFIN | 122 | Endothelin ETA | View |
| AURANOFIN | 208 | Serotonin 5-HT4 | View |
| AURANOFIN | 213 | Sigma1 | View |
| AURANOFIN | 92 | Adrenergic, Norepinephrine Transporter | View |
| AURANOFIN | 183 | Opiate mu | View |
| AURANOFIN | 168 | Muscarinic M2 | View |
| AURANOFIN | 638 | Testosterone | View |
| AURANOFIN | 624 | Cyclooxygenase COX-2 | View |
| AURANOFIN | 636 | Protein Tyrosine Kinase, Lck | View |
| AURANOFIN | 214 | Sigma2 | View |
| AURANOFIN | 117 | Dopamine D4.2 | View |
| AURANOFIN | 137 | Glucocorticoid | View |
| AURANOFIN | 635 | Protein Tyrosine Kinase, Fyn | View |
| AURANOFIN | 182 | Opiate kappa | View |
| AURANOFIN | 643 | CYP450-2D6 Inhibition | View |
| AURANOFIN | 116 | Dopamine D3 | View |
| AURANOFIN | 86 | Adrenergic alpha2C | View |
| AURANOFIN | 114 | Dopamine D2L | View |
| AURANOFIN | 640 | CYP450-1A2 Inhibition | View |